Colony Bankcorp, Inc. (CBAN)
NYSEFinancialsBanks - RegionalSnapshot 2026-09-04
$21.75+1.12%
Close 2026-09-04 · 1-day change
NYSEFinancialsBanks - RegionalSnapshot 2026-09-04
Broken: Recent financial performance freshly dropped to the bottom half of its industry.
Colony Bankcorp steadily grows revenue and net income, with revenue rising from $33.3M to $44.9M in two years. The company maintains a regular quarterly dividend of $0.12 per share. Recent acquisitions support growth and scale. Profitability is solid with a 2027 EPS guidance of $2.52.
Growth could slow if acquisitions fail to integrate well. Dividend and buyback progress is mixed, risking shareholder returns. Earnings could miss guidance if loan demand weakens or credit costs rise.
The price is about 6% above our fair value near $19, reflecting analysts' expectation of 30% revenue growth. Our model sees durable earnings growth but at a more moderate pace than the 30% revenue growth priced in.
Breaks if: EPS falls below $2.30 in FY27
Breaks if: Quarterly dividend falls below $0.11 per share
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a turnaround investment thesis with a focus on stabilizing and improving financial performance. The current state reflects challenges, particularly in revenue growth and management priorities, which have led to a mixed outlook.
The market seems to price CBAN as cheap compared to its peers, with a notable expectations gap. However, the current valuation does not fully reflect the recent decline in financial performance and the mixed signals from management.
Fundamentals may improve if the company successfully completes its merger with First Reliance Bancshares and maintains its cash dividend. However, recent financial results have shown weakness, indicating potential challenges ahead.
The thesis hinges on the successful execution of the merger and the ability to maintain revenue growth. Additionally, the performance of sector bellwethers like HDB, IBN, and PNC will be crucial in determining the overall momentum for CBAN.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The recent financial performance dropped to the bottom half of its industry. This change indicates a weaker reason to own the stock. However, the company did report a recent earnings beat, which adds some support.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue paying a consistent quarterly cash dividend to shareholders as a key capital allocation priority.
Breaks if: Total revenue falls below $160M in FY26
Focus on steady growth in revenue and net income through organic growth and acquisitions.
Stated as a priority in 2 of last 2 quarters. Revenue increased from $44.9 million in 2026-Q1 to $45.8 million in 2026-Q2, while net income rose from $8.2 million to $10.9 million over the same period. Management's focus on steady growth is reflected in these improving financial results, indicating delivery on this priority.
“Net income increased to $10.9 million, or $0.51 per diluted share, for the second quarter of 2026.”
“Net income was $8.2 million, or $0.39 per diluted share, for the first quarter of 2026.”
Breaks if: Material earnings or operational disruption from mergers
Over the next 1 to 3 years, CBAN's outlook will depend heavily on management's execution and external sector conditions. Not investment advice.